1. A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus. Issue 1 (March 2016) Authors: Kayaniyil, Sheena; Lozano-Ortega, Greta; Bennett, Heather; Johnsson, Kristina; Shaunik, Alka; Grandy, Susan; Kartman, Bernt Journal: Diabetes therapy Issue: Volume 7:Issue 1(2016) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan‐L trial. Issue 12 (3rd September 2019) Authors: Giorgino, Francesco; Shaunik, Alka; Liu, Minzhi; Saremi, Aramesh Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 12(2019) Page Start: 2712 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial. Issue 6 (29th April 2021) Authors: McCrimmon, Rory J.; Al Sifri, Saud; Emral, Rifat; Mohan, Viswanathan; Sauque‐Reyna, Leobardo; Trescolí, Carlos; Lalic, Nebojsa; Alvarez, Agustina; Demil, Nacima; Coudert, Mathieu; Shaunik, Alka; Bonnemaire, Mireille; Rosenstock, Julio Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 6(2021) Page Start: 1221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis. Issue 3 (28th March 2019) Authors: Raccah, Denis; Guerci, Bruno; Ajmera, Mayank; Davis, Keith; Meyers, Juliana; Lew, Elisheva; Shaunik, Alka; Blonde, Lawrence Journal: Endocrinology, diabetes & metabolism Issue: Volume 2:Issue 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data. Issue 7 (5th May 2021) Authors: Beachler, Daniel C.; Taylor, Devon H.; Anthony, Mary S.; Yin, Ruihua; Li, Ling; Saltus, Catherine W.; Li, Lin; Shaunik, Alka; Walsh, Kathleen E.; Rothman, Kenneth J.; Johannes, Catherine B.; Aroda, Vanita R.; Carr, Warner; Goldberg, Pinkus; Accardi, Andrew; O'Shura, John Shane; Sharma, Kristen; J... Journal: Pharmacoepidemiology and drug safety Issue: Volume 30:Issue 7(2021) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effectiveness of premixed insulin to achieve glycaemic control in type 2 diabetes: A retrospective UK cohort study. Issue 4 (26th January 2021) Authors: Jude, Edward B.; Trescoli, Carlos; Emral, Rifat; Ali, Amar; Lubwama, Robert; Palmer, Karen; Shaunik, Alka; Nanda, Nithya; Raskin, Philip; Gomez‐Peralta, Fernando Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 4(2021) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of efpeglenatide in key patient subgroups from the BALANCE randomized trial, stratified by pre-diabetes status, BMI, and age at baseline. Issue 1 (18th January 2022) Authors: Pratley, Richard E; Jacob, Stephan; Baek, Seungjae; Trautmann, Michael E; Hompesch, Marcus; Han, OakPil; Stewart, John; Sorli, Christopher H; Shaunik, Alka; Yoon, Kun-Ho Journal: BMJ open diabetes research and care Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon‐like peptide‐1 receptor agonists: a systematic literature review and indirect treatment comparison. Issue 11 (26th July 2020) Authors: Home, Philip D.; Aroda, Vanita R.; Blonde, Lawrence; Guyot, Patricia; Shaunik, Alka; Fazeli, Mir Sohail; Goswami, Hardik; Kalra, Sanjay; Pourrahmat, Mir‐Masoud Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 11(2020) Page Start: 2170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN). Issue 1 (29th September 2019) Authors: Jude, Edward B.; O'Leary, Caroline; Myland, Melissa; Nixon, Mark; Gooch, Nick; Shaunik, Alka; Lew, Elisheva Journal: Endocrinology, diabetes & metabolism Issue: Volume 3:Issue 1(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Gastrointestinal adverse events with insulin glargine/lixisenatide fixed‐ratio combination versus glucagon‐like peptide‐1 receptor agonists in people with type 2 diabetes mellitus: A network meta‐analysis. Issue 1 (22nd October 2020) Authors: Rayner, Christopher K.; Wu, Tongzhi; Aroda, Vanita R.; Whittington, Craig; Kanters, Steve; Guyot, Patricia; Shaunik, Alka; Horowitz, Michael Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 1(2021) Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗